You have free access to this content

Hepatology

Cover image for Hepatology

May 2009

Volume 49, Issue 5

Pages 1403–1784

  1. Master's Persective

    1. Top of page
    2. Master's Persective
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
  2. Comments from the Editors

    1. Top of page
    2. Master's Persective
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
      Hepatology as a model for health care (pages 1419–1420)

      Keith Lindor and Rachel Lindor

      Version of Record online: 6 APR 2009 | DOI: 10.1002/hep.22986

  3. Editorials

    1. Top of page
    2. Master's Persective
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Hepatic progenitor cell–mediated regeneration and fibrosis: Chicken or egg? (pages 1424–1426)

      Andrew D. Clouston, Julie R. Jonsson and Elizabeth E. Powell

      Version of Record online: 9 FEB 2009 | DOI: 10.1002/hep.22893

    3. You have free access to this content
  4. Viral Hepatitis

    1. Top of page
    2. Master's Persective
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA–negative patients are associated with virological relapse (pages 1442–1448)

      Monica Basso, Edoardo G. Giannini, Francesco Torre, Sabrina Blanchi, Vincenzo Savarino and Antonino Picciotto

      Version of Record online: 23 DEC 2008 | DOI: 10.1002/hep.22810

    3. You have free access to this content
      Seroconversion to hepatitis C virus alternate reading frame protein during acute infection (pages 1449–1459)

      Yoann Morice, Maxime Ratinier, Ahmed Miladi, Stéphane Chevaliez, Georgios Germanidis, Heiner Wedemeyer, Syria Laperche, Jean-Pierre Lavergne and Jean-Michel Pawlotsky

      Version of Record online: 5 JAN 2009 | DOI: 10.1002/hep.22821

    4. You have free access to this content
      The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naïve hepatitis C patients (pages 1460–1468)

      Robert Flisiak, Saya V. Feinman, Maciej Jablkowski, Andrzej Horban, Wieslaw Kryczka, Małgorzata Pawlowska, Jenny E. Heathcote, Giuseppe Mazzella, Carmen Vandelli, Valérie Nicolas-Métral, Pierre Grosgurin, Jorge S. Liz, Pietro Scalfaro, Hervé Porchet and Raf Crabbé

      Version of Record online: 4 FEB 2009 | DOI: 10.1002/hep.22835

    5. You have free access to this content
      Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways (pages 1469–1482)

      Mohamed Hassan, Denis Selimovic, Hanan Ghozlan and Ola Abdel-kader

      Version of Record online: 23 JAN 2009 | DOI: 10.1002/hep.22849

    6. You have free access to this content
      Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model (pages 1483–1491)

      Saleem Kamili, Vitini Sozzi, Geoff Thompson, Katie Campbell, Christopher M. Walker, Stephen Locarnini and Krzysztof Krawczynski

      Version of Record online: 23 DEC 2008 | DOI: 10.1002/hep.22796

    7. You have free access to this content
      Multiepitope peptide-loaded virus-like particles as a vaccine against hepatitis B virus–related hepatocellular carcinoma (pages 1492–1502)

      Fei-Xiang Ding, Fang Wang, Yi-Ming Lu, Ka Li, Kai-Hui Wang, Xiao-Wen He and Shu-Han Sun

      Version of Record online: 6 JAN 2009 | DOI: 10.1002/hep.22816

    8. You have free access to this content
      Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy (pages 1503–1514)

      Daniel J. Tenney, Ronald E. Rose, Carl J. Baldick, Kevin A. Pokornowski, Betsy J. Eggers, Jie Fang, Michael J. Wichroski, Dong Xu, Joanna Yang, Richard B. Wilber and Richard J. Colonno

      Version of Record online: 4 FEB 2009 | DOI: 10.1002/hep.22841

    9. You have free access to this content
      Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3β kinase pathways (pages 1515–1524)

      Wan-Jen Yang, Ching-Ju Chang, Shiou-Hwei Yeh, Wei-Hsiang Lin, Sheng-Han Wang, Ting-Fen Tsai, Ding-Shinn Chen and Pei-Jer Chen

      Version of Record online: 4 FEB 2009 | DOI: 10.1002/hep.22833

  5. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Master's Persective
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population (pages 1537–1544)

      Amalia Gastaldelli, Michaela Kozakova, Kurt Højlund, Allan Flyvbjerg, Angela Favuzzi, Asimina Mitrakou, Beverley Balkau and The RISC Investigators

      Version of Record online: 23 JAN 2009 | DOI: 10.1002/hep.22845

    3. You have free access to this content
      Fibrin accumulation plays a critical role in the sensitization to lipopolysaccharide-induced liver injury caused by ethanol in mice (pages 1545–1553)

      Juliane I. Beier, James P. Luyendyk, Luping Guo, Claudia von Montfort, Donald E. Staunton and Gavin E. Arteel

      Version of Record online: 23 JAN 2009 | DOI: 10.1002/hep.22847

    4. You have free access to this content
      Taurine supplementation prevents ethanol-induced decrease in serum adiponectin and reduces hepatic steatosis in rats (pages 1554–1562)

      Xiaocong Chen, Becky M. Sebastian, Hui Tang, Megan M. McMullen, Armend Axhemi, Donald W. Jacobsen and Laura E. Nagy

      Version of Record online: 30 DEC 2008 | DOI: 10.1002/hep.22811

  6. Hepatobiliary Malignancies

    1. Top of page
    2. Master's Persective
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
      Association between hypothyroidism and hepatocellular carcinoma: A case-control study in the United States (pages 1563–1570)

      Manal M. Hassan, Ahmed Kaseb, Donghui Li, Yehuda Z. Patt, Jean-Nicolas Vauthey, Melanie B. Thomas, Steven A. Curley, Margaret R. Spitz, Steven I. Sherman, Eddie K. Abdalla, Marta Davila, Richard D. Lozano, Deena M. Hassan, Wenyaw Chan, Thomas D. Brown and James L. Abbruzzese

      Version of Record online: 23 DEC 2008 | DOI: 10.1002/hep.22793

    2. You have free access to this content
      MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma (pages 1571–1582)

      Wei-Chih Tsai, Paul Wei-Che Hsu, Tsung-Ching Lai, Gar-Yang Chau, Ching-Wen Lin, Chun-Ming Chen, Chien-Der Lin, Yu-Lun Liao, Jui-Ling Wang, Yat-Pang Chau, Ming-Ta Hsu, Michael Hsiao, Hsien-Da Huang and Ann-Ping Tsou

      Version of Record online: 23 DEC 2008 | DOI: 10.1002/hep.22806

    3. You have free access to this content
      Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion (pages 1583–1594)

      Carmen Chak-Lui Wong, Chun-Ming Wong, Edmund Kwok-Kwan Tung, Kwan Man and Irene Oi-Lin Ng

      Version of Record online: 4 FEB 2009 | DOI: 10.1002/hep.22836

    4. You have free access to this content
      MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3 (pages 1595–1601)

      Florin M. Selaru, Alexandru V. Olaru, Takatsugu Kan, Stefan David, Yulan Cheng, Yuriko Mori, Jian Yang, Bogdan Paun, Zhe Jin, Rachana Agarwal, James P. Hamilton, John Abraham, Christos Georgiades, Hector Alvarez, Perumal Vivekanandan, Wayne Yu, Anirban Maitra, Michael Torbenson, Paul J. Thuluvath, Gregory J. Gores, Nicholas F. LaRusso, Ralph Hruban and Stephen J. Meltzer

      Version of Record online: 4 FEB 2009 | DOI: 10.1002/hep.22838

    5. You have free access to this content
      Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas (pages 1602–1609)

      Marc-Oliver Riener, Frank Stenner, Heike Liewen, Christopher Soll, Stefan Breitenstein, Bernhard Cornelius Pestalozzi, Panagiotis Samaras, Nicole Probst-Hensch, Claus Hellerbrand, Beat Müllhaupt, Pierre-Alain Clavien, Marcus Bahra, Peter Neuhaus, Peter Wild, Florian Fritzsche, Holger Moch, Wolfram Jochum and Glen Kristiansen

      Version of Record online: 20 JAN 2009 | DOI: 10.1002/hep.22843

  7. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Master's Persective
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
      Impact of pretransplant hyponatremia on outcome following liver transplantation (pages 1610–1615)

      Byung Cheol Yun, W. Ray Kim, Joanne T. Benson, Scott W. Biggins, Terry M. Therneau, Walter K. Kremers, Charles B. Rosen and Goran B. Klintmalm

      Version of Record online: 23 JAN 2009 | DOI: 10.1002/hep.22846

  8. Liver Injury/Regeneration

    1. Top of page
    2. Master's Persective
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE-induced murine model of chronic liver injury (pages 1625–1635)

      Noémi K. M. Van Hul, Jorge Abarca-Quinones, Christine Sempoux, Yves Horsmans and Isabelle A. Leclercq

      Version of Record online: 5 JAN 2009 | DOI: 10.1002/hep.22820

    3. You have free access to this content
      Pioglitazone promotes survival and prevents hepatic regeneration failure after partial hepatectomy in obese and diabetic KK-Ay mice (pages 1636–1644)

      Tomonori Aoyama, Kenichi Ikejima, Kazuyoshi Kon, Kyoko Okumura, Kumiko Arai and Sumio Watanabe

      Version of Record online: 9 FEB 2009 | DOI: 10.1002/hep.22828

    4. You have free access to this content
  9. Liver Biology/Pathobiology

    1. Top of page
    2. Master's Persective
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
      Locating the stem cell niche and tracing hepatocyte lineages in human liver (pages 1655–1663)

      Tariq G. Fellous, Shahriar Islam, Paul J. Tadrous, George Elia, Hemant M. Kocher, Satyajit Bhattacharya, Lisa Mears, Douglas M. Turnbull, Robert W. Taylor, Laura C. Greaves, Patrick F. Chinnery, Geoffery Taylor, Stuart A.C. McDonald, Nicholas A. Wright and Malcolm R. Alison

      Version of Record online: 23 DEC 2008 | DOI: 10.1002/hep.22791

    2. You have free access to this content
      Systemic antigen cross-presented by liver sinusoidal endothelial cells induces liver-specific CD8 T-cell retention and tolerization (pages 1664–1672)

      Nanette von Oppen, Anna Schurich, Silke Hegenbarth, Dirk Stabenow, Rene Tolba, Ralf Weiskirchen, Albert Geerts, Waldemar Kolanus, Percy Knolle and Linda Diehl

      Version of Record online: 23 DEC 2008 | DOI: 10.1002/hep.22795

    3. You have free access to this content
      ABC-transporters are localized in caveolin-1-positive and reggie-1-negative and reggie-2-negative microdomains of the canalicular membrane in rat hepatocytes (pages 1673–1682)

      Manfred G. Ismair, Stephanie Häusler, Claudia A. Stuermer, Christelle Guyot, Peter J. Meier, Jürgen Roth and Bruno Stieger

      Version of Record online: 23 DEC 2008 | DOI: 10.1002/hep.22807

    4. You have free access to this content
      Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride (pages 1683–1694)

      Ogyi Park, Won-IL Jeong, Lei Wang, Hua Wang, Zhe-Xiong Lian, M. Eric Gershwin and Bin Gao

      Version of Record online: 23 DEC 2008 | DOI: 10.1002/hep.22813

    5. You have free access to this content
      Endotoxin uptake in mouse liver is blocked by endotoxin pretreatment through a suppressor of cytokine signaling-1–dependent mechanism (pages 1695–1708)

      Melanie J. Scott, Shubing Liu, Richard A. Shapiro, Yoram Vodovotz and Timothy R. Billiar

      Version of Record online: 9 FEB 2009 | DOI: 10.1002/hep.22839

    6. You have free access to this content
      Exogenous thioredoxin prevents ethanol-induced oxidative damage and apoptosis in mouse liver (pages 1709–1717)

      Jessica I. Cohen, Sanjoy Roychowdhury, Patricia M. DiBello, Donald W. Jacobsen and Laura E. Nagy

      Version of Record online: 4 FEB 2009 | DOI: 10.1002/hep.22837

    7. You have free access to this content
      Age-related decrease in proteasome expression contributes to defective nuclear factor-κB activation during hepatic ischemia/reperfusion (pages 1718–1728)

      Nadine Huber, Nozomu Sakai, Thorsten Eismann, Thomas Shin, Satoshi Kuboki, John Blanchard, Rebecca Schuster, Michael J. Edwards, Hector R. Wong and Alex B. Lentsch

      Version of Record online: 9 FEB 2009 | DOI: 10.1002/hep.22840

  10. AASLD Practice Guidelines

    1. Top of page
    2. Master's Persective
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
      Vascular disorders of the liver (pages 1729–1764)

      Laurie D. DeLeve, Dominique-Charles Valla and Guadalupe Garcia-Tsao

      Version of Record online: 8 DEC 2008 | DOI: 10.1002/hep.22772

  11. Hepatology Elsewhere

    1. Top of page
    2. Master's Persective
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      Closing the gap: The tight junction protein occludin and hepatitis C virus entry (pages 1770–1772)

      Nicholas S. Eyre, Thomas F. Baumert and Michael R. Beard

      Version of Record online: 28 APR 2009 | DOI: 10.1002/hep.22935

  12. Image of the Month

    1. Top of page
    2. Master's Persective
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
  13. Correspondence

    1. Top of page
    2. Master's Persective
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Insulin resistance in prediction of esophageal varices (pages 1775–1776)

      Teoman Dogru, Cemal Nuri Ercin, Serkan Tapan, Zülfikar Polat, Mustafa Gulsen and Sait Bagci

      Version of Record online: 29 MAR 2009 | DOI: 10.1002/hep.22875

    3. You have free access to this content
      Reply: (page 1776)

      Salvatore Petta, Calogero Cammà and Antonio Craxfi

      Version of Record online: 11 FEB 2009 | DOI: 10.1002/hep.22905

    4. You have free access to this content
      Glutathione S-transferase M1 and T1 null genotypes increase susceptibility to drug-induced liver injury (page 1777)

      Virginia Leiro Fernández, Alberto Fernández-Villar, Rafael Vázquez Gallardo and Diana Valverde Pérez

      Version of Record online: 6 APR 2009 | DOI: 10.1002/hep.22910

    5. You have free access to this content
      Reply: (pages 1777–1779)

      M. Isabel Lucena, Carmen Martínez, Raúl J. Andrade, Elena García-Martín, Eugenia Ulzurrun and José A. G. Agúndez

      Version of Record online: 7 APR 2009 | DOI: 10.1002/hep.22922

    6. You have free access to this content
      Hepatitis B virus clearance rate estimates (pages 1779–1780)

      Harel Dahari, Scott J. Cotler, Thomas J. Layden and Alan S. Perelson

      Version of Record online: 2 FEB 2009 | DOI: 10.1002/hep.22874

    7. You have free access to this content
      Reply: (pages 1780–1781)

      Maura Dandri, Jörg Petersen and John M. Murray

      Version of Record online: 7 APR 2009 | DOI: 10.1002/hep.22918

    8. You have free access to this content
      Hemochromatosis: Platelets and aspartate aminotransferase are useful high-degree fibrosis marker (page 1781)

      Agustin Castiella, Eva Zapata and Pedro Otazua

      Version of Record online: 7 APR 2009 | DOI: 10.1002/hep.22925

    9. You have free access to this content
    10. You have free access to this content
      Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients (pages 1782–1783)

      Paolo Muratori, Alessandro Granito, Georgios Pappas and Luigi Muratori

      Version of Record online: 28 APR 2009 | DOI: 10.1002/hep.22825

    11. You have free access to this content
      Reply: (page 1783)

      Elke Hennes, Christoph Schramm and Ansgar Lohse

      Version of Record online: 7 APR 2009 | DOI: 10.1002/hep.22947

    12. You have free access to this content
    13. You have free access to this content
      Reply: (page 1784)

      Michael L. Schilsky, William Lee and Frank Wiands

      Version of Record online: 7 APR 2009 | DOI: 10.1002/hep.22954

SEARCH

SEARCH BY CITATION